annual EBITDA:
-$789.33M-$818.61M(-2795.52%)Summary
- As of today (May 29, 2025), EXAS annual EBITDA is -$789.33 million, with the most recent change of -$818.61 million (-2795.52%) on December 31, 2024.
- During the last 3 years, EXAS annual EBITDA has fallen by -$140.05 million (-21.57%).
- EXAS annual EBITDA is now -2795.52% below its all-time high of $29.28 million, reached on December 31, 2023.
Performance
EXAS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$38.11M+$776.46M(+95.32%)Summary
- As of today (May 29, 2025), EXAS quarterly EBITDA is -$38.11 million, with the most recent change of +$776.46 million (+95.32%) on March 31, 2025.
- Over the past year, EXAS quarterly EBITDA has increased by +$9.74 million (+20.35%).
- EXAS quarterly EBITDA is now -163.69% below its all-time high of $59.84 million, reached on September 30, 2023.
Performance
EXAS quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$792.20M+$9.74M(+1.21%)Summary
- As of today (May 29, 2025), EXAS TTM EBITDA is -$792.20 million, with the most recent change of +$9.74 million (+1.21%) on March 31, 2025.
- Over the past year, EXAS TTM EBITDA has dropped by -$788.53 million (-21474.10%).
- EXAS TTM EBITDA is now -1485.28% below its all-time high of $57.19 million, reached on June 30, 2024.
Performance
EXAS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EXAS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -2795.5% | +20.4% | -10000.0% |
| 3 y3 years | -21.6% | +71.3% | -42.8% |
| 5 y5 years | -127.2% | +59.4% | -110.9% |
EXAS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -2795.5% | at low | -163.7% | +95.3% | -1485.3% | +1.2% |
| 5 y | 5-year | -2795.5% | at low | -163.7% | +95.3% | -1485.3% | +10.6% |
| alltime | all time | -2795.5% | at low | -163.7% | +95.3% | -1485.3% | +10.6% |
EXAS EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$38.11M(-95.3%) | -$792.20M(-1.2%) |
| Dec 2024 | -$789.33M(-2795.5%) | -$814.57M(-3279.9%) | -$801.94M(-3592.2%) |
| Sep 2024 | - | $25.62M(-26.5%) | $22.96M(-59.8%) |
| Jun 2024 | - | $34.87M(-172.9%) | $57.19M(-1657.4%) |
| Mar 2024 | - | -$47.85M(-563.1%) | -$3.67M(-121.8%) |
| Dec 2023 | $29.28M(-107.0%) | $10.33M(-82.7%) | $16.82M(-124.0%) |
| Sep 2023 | - | $59.84M(-330.2%) | -$69.99M(-69.5%) |
| Jun 2023 | - | -$25.99M(-5.0%) | -$229.34M(-27.1%) |
| Mar 2023 | - | -$27.35M(-64.2%) | -$314.79M(-25.1%) |
| Dec 2022 | -$421.11M(-35.1%) | -$76.48M(-23.1%) | -$420.14M(-19.2%) |
| Sep 2022 | - | -$99.52M(-10.7%) | -$520.17M(-4.0%) |
| Jun 2022 | - | -$111.44M(-16.0%) | -$542.02M(-2.3%) |
| Mar 2022 | - | -$132.70M(-24.8%) | -$554.92M(-14.5%) |
| Dec 2021 | -$649.28M(-0.7%) | -$176.51M(+45.4%) | -$649.28M(-23.5%) |
| Sep 2021 | - | -$121.36M(-2.4%) | -$848.33M(-4.3%) |
| Jun 2021 | - | -$124.34M(-45.2%) | -$886.08M(+12.7%) |
| Mar 2021 | - | -$227.07M(-39.5%) | -$786.21M(+20.4%) |
| Dec 2020 | -$653.88M(+88.2%) | -$375.56M(+136.0%) | -$652.89M(+25.0%) |
| Sep 2020 | - | -$159.11M(+550.3%) | -$522.14M(+37.0%) |
| Jun 2020 | - | -$24.47M(-73.9%) | -$381.16M(+1.5%) |
| Mar 2020 | - | -$93.75M(-61.7%) | -$375.69M(+8.1%) |
| Dec 2019 | -$347.46M(+195.8%) | -$244.81M(+1250.3%) | -$347.46M(+146.4%) |
| Sep 2019 | - | -$18.13M(-4.6%) | -$141.03M(-6.8%) |
| Jun 2019 | - | -$19.00M(-71.0%) | -$151.38M(-2.4%) |
| Mar 2019 | - | -$65.53M(+70.7%) | -$155.02M(+32.0%) |
| Dec 2018 | -$117.46M(+18.9%) | -$38.38M(+34.8%) | -$117.46M(+21.9%) |
| Sep 2018 | - | -$28.47M(+25.8%) | -$96.34M(+6.1%) |
| Jun 2018 | - | -$22.64M(-19.0%) | -$90.84M(-4.6%) |
| Mar 2018 | - | -$27.96M(+61.9%) | -$95.19M(-3.7%) |
| Dec 2017 | -$98.82M(-36.4%) | -$17.27M(-24.8%) | -$98.82M(-14.5%) |
| Sep 2017 | - | -$22.97M(-14.9%) | -$115.55M(-9.3%) |
| Jun 2017 | - | -$26.99M(-14.6%) | -$127.33M(-10.5%) |
| Mar 2017 | - | -$31.60M(-7.1%) | -$142.21M(-8.6%) |
| Dec 2016 | -$155.49M(+3.6%) | -$34.00M(-2.2%) | -$155.53M(-1.8%) |
| Sep 2016 | - | -$34.75M(-17.0%) | -$158.36M(-3.9%) |
| Jun 2016 | - | -$41.87M(-6.8%) | -$164.78M(+2.7%) |
| Mar 2016 | - | -$44.91M(+21.9%) | -$160.52M(+7.1%) |
| Dec 2015 | -$150.05M(+55.9%) | -$36.83M(-10.6%) | -$149.82M(+4.4%) |
| Sep 2015 | - | -$41.17M(+9.5%) | -$143.56M(+7.4%) |
| Jun 2015 | - | -$37.60M(+9.9%) | -$133.66M(+16.3%) |
| Mar 2015 | - | -$34.22M(+11.9%) | -$114.91M(+19.5%) |
| Dec 2014 | -$96.23M(+113.9%) | -$30.57M(-2.2%) | -$96.14M(+24.5%) |
| Sep 2014 | - | -$31.27M(+65.9%) | -$77.21M(+36.0%) |
| Jun 2014 | - | -$18.85M(+22.0%) | -$56.77M(+13.9%) |
| Mar 2014 | - | -$15.45M(+32.7%) | -$49.85M(+11.1%) |
| Dec 2013 | -$44.98M(-12.5%) | -$11.64M(+7.5%) | -$44.88M(-4.3%) |
| Sep 2013 | - | -$10.83M(-9.3%) | -$46.87M(-3.7%) |
| Jun 2013 | - | -$11.94M(+14.0%) | -$48.69M(-5.2%) |
| Mar 2013 | - | -$10.47M(-23.2%) | -$51.38M(+0.2%) |
| Dec 2012 | -$51.40M | -$13.63M(+7.8%) | -$51.30M(+8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$12.64M(-13.5%) | -$47.24M(+11.6%) |
| Jun 2012 | - | -$14.62M(+40.7%) | -$42.32M(+23.5%) |
| Mar 2012 | - | -$10.39M(+8.5%) | -$34.26M(+21.5%) |
| Dec 2011 | -$28.21M(+150.1%) | -$9.58M(+24.0%) | -$28.21M(+27.8%) |
| Sep 2011 | - | -$7.73M(+17.7%) | -$22.07M(+24.9%) |
| Jun 2011 | - | -$6.56M(+51.4%) | -$17.67M(+30.6%) |
| Mar 2011 | - | -$4.33M(+26.0%) | -$13.54M(+20.0%) |
| Dec 2010 | -$11.28M(+24.3%) | -$3.44M(+3.2%) | -$11.28M(+16.8%) |
| Sep 2010 | - | -$3.33M(+37.4%) | -$9.65M(+30.8%) |
| Jun 2010 | - | -$2.43M(+17.0%) | -$7.38M(-0.0%) |
| Mar 2010 | - | -$2.08M(+14.1%) | -$7.38M(-18.7%) |
| Dec 2009 | -$9.07M(+3.8%) | -$1.82M(+71.9%) | -$9.07M(-1.0%) |
| Sep 2009 | - | -$1.06M(-56.4%) | -$9.17M(-7.2%) |
| Jun 2009 | - | -$2.43M(-35.6%) | -$9.88M(+4.3%) |
| Mar 2009 | - | -$3.77M(+96.8%) | -$9.48M(+13.5%) |
| Dec 2008 | -$8.74M(-25.1%) | -$1.92M(+8.1%) | -$8.35M(-18.7%) |
| Sep 2008 | - | -$1.77M(-12.4%) | -$10.28M(+5.3%) |
| Jun 2008 | - | -$2.02M(-23.5%) | -$9.77M(-0.4%) |
| Mar 2008 | - | -$2.64M(-31.2%) | -$9.81M(+5.3%) |
| Dec 2007 | -$11.67M(-13.5%) | -$3.84M(+205.2%) | -$9.31M(+23.8%) |
| Sep 2007 | - | -$1.26M(-39.0%) | -$7.52M(-22.2%) |
| Jun 2007 | - | -$2.06M(-3.8%) | -$9.67M(-13.4%) |
| Mar 2007 | - | -$2.15M(+4.5%) | -$11.16M(-17.3%) |
| Dec 2006 | -$13.50M(-10.1%) | -$2.05M(-39.7%) | -$13.50M(-6.6%) |
| Sep 2006 | - | -$3.40M(-4.4%) | -$14.46M(-1.2%) |
| Jun 2006 | - | -$3.56M(-20.6%) | -$14.63M(-4.3%) |
| Mar 2006 | - | -$4.48M(+48.8%) | -$15.28M(+1.8%) |
| Dec 2005 | -$15.01M(-21.8%) | -$3.01M(-15.8%) | -$15.01M(-10.4%) |
| Sep 2005 | - | -$3.58M(-15.0%) | -$16.75M(-5.6%) |
| Jun 2005 | - | -$4.21M(+0.2%) | -$17.75M(-1.3%) |
| Mar 2005 | - | -$4.21M(-11.6%) | -$17.99M(-6.3%) |
| Dec 2004 | -$19.20M(-33.4%) | -$4.75M(+3.8%) | -$19.20M(-5.2%) |
| Sep 2004 | - | -$4.58M(+2.9%) | -$20.25M(-10.5%) |
| Jun 2004 | - | -$4.45M(-17.7%) | -$22.64M(-12.4%) |
| Mar 2004 | - | -$5.41M(-6.9%) | -$25.84M(-8.7%) |
| Dec 2003 | -$28.84M(+0.5%) | -$5.81M(-16.5%) | -$28.30M(-0.9%) |
| Sep 2003 | - | -$6.96M(-9.0%) | -$28.56M(-1.8%) |
| Jun 2003 | - | -$7.66M(-2.7%) | -$29.08M(-0.2%) |
| Mar 2003 | - | -$7.87M(+29.6%) | -$29.15M(+1.6%) |
| Dec 2002 | -$28.69M(+14.1%) | -$6.07M(-18.8%) | -$28.69M(-2.5%) |
| Sep 2002 | - | -$7.48M(-3.2%) | -$29.43M(+5.2%) |
| Jun 2002 | - | -$7.72M(+4.2%) | -$27.98M(+5.4%) |
| Mar 2002 | - | -$7.41M(+8.7%) | -$26.55M(+5.7%) |
| Dec 2001 | -$25.13M(+158.0%) | -$6.82M(+13.1%) | -$25.13M(+37.2%) |
| Sep 2001 | - | -$6.03M(-4.3%) | -$18.32M(+49.0%) |
| Jun 2001 | - | -$6.30M(+5.2%) | -$12.29M(+105.2%) |
| Mar 2001 | - | -$5.99M | -$5.99M |
| Dec 2000 | -$9.74M(+101.3%) | - | - |
| Dec 1999 | -$4.84M(+20.3%) | - | - |
| Dec 1998 | -$4.02M | - | - |
FAQ
- What is Exact Sciences annual EBITDA?
- What is the all time high annual EBITDA for Exact Sciences?
- What is Exact Sciences annual EBITDA year-on-year change?
- What is Exact Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Exact Sciences?
- What is Exact Sciences quarterly EBITDA year-on-year change?
- What is Exact Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Exact Sciences?
- What is Exact Sciences TTM EBITDA year-on-year change?
What is Exact Sciences annual EBITDA?
The current annual EBITDA of EXAS is -$789.33M
What is the all time high annual EBITDA for Exact Sciences?
Exact Sciences all-time high annual EBITDA is $29.28M
What is Exact Sciences annual EBITDA year-on-year change?
Over the past year, EXAS annual EBITDA has changed by -$818.61M (-2795.52%)
What is Exact Sciences quarterly EBITDA?
The current quarterly EBITDA of EXAS is -$38.11M
What is the all time high quarterly EBITDA for Exact Sciences?
Exact Sciences all-time high quarterly EBITDA is $59.84M
What is Exact Sciences quarterly EBITDA year-on-year change?
Over the past year, EXAS quarterly EBITDA has changed by +$9.74M (+20.35%)
What is Exact Sciences TTM EBITDA?
The current TTM EBITDA of EXAS is -$792.20M
What is the all time high TTM EBITDA for Exact Sciences?
Exact Sciences all-time high TTM EBITDA is $57.19M
What is Exact Sciences TTM EBITDA year-on-year change?
Over the past year, EXAS TTM EBITDA has changed by -$788.53M (-21474.10%)